Introduction
============

A total of \~2-10% of women suffer from endometriosis and 50% of them have infertility issues ([@b1-ijmm-44-06-2145]), mainly of the estrogen-dependent inflammatory type ([@b2-ijmm-44-06-2145],[@b3-ijmm-44-06-2145]). The glandular epithelium and basement membrane of human endometrium undergo periodic changes in gene expression, which must be synchronized to allow the opening of the implantation window. Any abnormality in gene expression could lead to a small or absent window. The abnormal inflammatory state caused by endometriosis impairs endometrial receptivity ([@b4-ijmm-44-06-2145]).

Long non-coding RNAs (lncRNAs) are non-coding RNAs with a length of \>200 nucleotides and a wide range of biological functions. A number of studies reported various lncRNAs to be associated with endometriosis and compromised fertility ([@b5-ijmm-44-06-2145]-[@b8-ijmm-44-06-2145]) A total of two genome-wide screening studies showed that there were 1,000 lncRNA ([@b9-ijmm-44-06-2145]) and 1,300 mRNA ([@b10-ijmm-44-06-2145]) transcripts that were abnormally expressed between eutopic and ectopic endometrial tissues of patients with endometriosis. Another study revealed that 1,277 lncRNAs and 1,216 mRNAs were differentially expressed between the eutopic and ectopic endometrium of patients with endometriosis during the late secretory phase ([@b11-ijmm-44-06-2145]). Taken together, these studies highlight the important regulatory roles of lncRNAs in endometriosis.

In the present study, the difficulty of obtaining clinical specimens of the endometrium during the implantation window was taken into consideration. Therefore, autologous endometrial transplantation was used to establish a model of endometriosis in Sprague-Dawley rats. The present study aimed to determine the changes in lncRNAs and mRNAs in the uterine tissues of those rats during the implantation window, using microarrays. The present study hypothesized that the abnormalities in lncRNA and mRNA profiles have significant effects on the implantation ability of uterine tissues in rats with endometriosis during the implantation window, which could be an important cause of endometrial receptivity impairment in endometriosis.

Materials and methods
=====================

Ethics statement
----------------

The present study was approved by the Experimental Animal Center of the Peking Union Medical College Hospital and Chinese Academy of Medical Sciences (permit no. XHDW-2016-000). All experiments were performed in accordance with the principles of experimental animal management and protection. The rats were humanely cared for and sacrificed to prevent suffering.

Experimental animals and collection of specimens
------------------------------------------------

Clean, sexually mature and non-pregnant Sprague-Dawley female (n=35) and male (n=10) rats were selected. The age of the female rats was 60-70 days and their weight was 200±10 g. The weight of the male rats was 380±10 g (age, 60-70 days). All rats were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd., and they were kept in the specific pathogen-free facility of the Laboratory Animal Center of Peking Union Medical College Hospital. Room temperature was 20-25°C and relative humidity was 45-60%. The rats were housed five per cage. All rats were kept under 14-h light/10-h dark cycle. They received sterilized feed and water *ad libitum*. They were adaptively fed for 2-3 days before experiments. The vaginal smear method was used to determine the estrous cycle of each female rat, which was usually 4-5 days.

The 35 female rats were divided into three groups: Endometriosis group (n=13), adipose tissue control group (n=8) and blank control group (n=14). After the observation of three estrous cycles, the autologous transendocardial transplantation method described by Vernon and Wilson ([@b12-ijmm-44-06-2145]) was performed, but with slight improvements. In the endometriosis group, a segment of autologous uterine tissue was collected and transplanted onto the abdominal wall in the fourth estrus cycle. Pentobarbital sodium (5%, 50 mg/kg, i.p.) was used for anesthesia. The rats were placed in a supine position and the abdominal skin was prepared. A longitudinal abdominal incision (5 cm) was made to open the abdominal cavity and to find the Y-shaped uterus. The left uterine horn was lifted and uterine tissue (1 cm) was collected and quickly placed in a culture dish with saline water. The extra adipose tissues outside the serous layer were removed. A longitudinal incision of the uterine cavity was made and two pieces (5×5 mm) were sutured on both sides of the abdominal wall at sites rich in blood vessels. Then the abdominal incision was sutured layer by layer.

In the adipose tissue control group, eight female rats were randomly selected. They underwent the same surgery as in the endometriosis group, but the left uterine horn was ligated and two pieces of adipose tissues (5×5 mm) were collected from the abdomen and sutured onto both sides of the abdominal wall. In the blank control group, no surgery was performed.

A total of 28 days after operating, the rats in the endometriosis and adipose tissue groups were re-operated to observe the growth, invasion and adhesion of the transplanted endometrium. Growth of ectopic endometrium (the transplanted tissues were 5×5 mm), tissue edema (as a sign of inflammation) and vesicle formation were observed by the naked eye. The models were considered successful if the transplanted endometrium has grown by at least 2-fold. The model success rate was calculated as the number of successful models divided by the total number of animals that underwent modeling. The scoring criteria of the ectopic uterine tissue growth were: Score 0, no epithelium; score 1, poorly preserved epithelium; score 2, moderately preserved epithelium; and score 3, well preserved epithelium ([@b13-ijmm-44-06-2145],[@b14-ijmm-44-06-2145]). The abdominal incision was sutured layer by layer. All rats survived and were prepared for mating.

A total of 10 male rats were kept in different cages. The female rats were placed in the cages with one male rat at 18:00 every night and a tray was placed under each cage. At 8:00-9:00 the next morning, the trays were checked for vaginal plugs and vaginal smear examinations were carried out. If a vaginal plug and sperm were observed under the microscope at the same time, it was considered to be the 1st day of pregnancy (D1) ([@b15-ijmm-44-06-2145]), and mating was not conducted anymore. On the 5th day of pregnancy (D5) \[i.e., during the short implanting window; implantation occurs on day 5 in rats ([@b15-ijmm-44-06-2145])\], female rats were sacrificed to collect the uterine tissues. The tissues were divided into two parts. One part was put in 10% formalin at 4°C for at least 24 h for subsequent hematoxylin and eosin (H&E) staining and immunohistochemistry. The other part was quickly put into liquid nitrogen at -80°C for gene chip analysis and reverse transcription-quantitative (RT-q)PCR. All experiments were performed using the samples from the same rats in each group.

RNA extraction
--------------

According to the manufacturer\'s protocol, TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.) was used to extract the total RNA from the uterine tissues (100 mg). RNA was purified using the mirVana miRNA Isolation kit (Ambion; Thermo Fisher Scientific, Inc.). RNA concentration and purity were determined by spectrophotometry (NanoDrop ND-1000; Thermo Fisher Scientific, Inc.) to measure optical density at 260/280 nm. The RNA 6000 Nano Lab-on-a-Chip kit and the Bioanalyzer 2100 (Agilent Technologies, Inc.) were used and RNA integrity was verified by electrophoresis on formaldehyde (1%) gels. The tissues with RNA integrity \>6 were selected for the subsequent experiments.

Microarray imaging and data analysis
------------------------------------

Complementary(c) DNA was synthesized from 5 *µ*l total RNA. The GeeDom^®^ biochip (CapitalBio Corp.) labeling kit was used. The Nucleospin^®^ Extract II kit (Macherey-Nagel, GmbH) was used to purify the labeled products. The rat lncRNA+mRNA Array V1.0 (8×60K format, the sequence included 4,974 control probes; Agilent Technologies, Inc.) was used for hybridization. The probes in each sequence represented 22,020 rat lncRNAs and 30,254 rat mRNAs. These lncRNA and mRNA probes sequences referred to multiple databases including NCBI RefSeq (<https://www.ncbi.nlm.nih.gov/refseq/>), Ensembl (<http://www.ensembl.org/index.html>), UCSC genome browser (<http://genome.ucsc.edu/>), NONCODE V4.0 (<http://www.noncode.org>) and UCR (<https://users.soe.ucsc.edu/~jill/ultra.html>) ([@b16-ijmm-44-06-2145]). Each RNA is detected by the probe at least 1-2 times and each microarray includes 4,974 probes.

After hybridization, the chip was washed in the GeeDom^®^ Slide Washer 8. The Agilent chip scanner (G2565CA) was used to scan the chip. The Agilent Feature Extraction (v10.7) software (Agilent Technologies, Inc.) was used to analyze the images. The GeneSpring software V13.0 (Agilent Technologies, Inc.) was used for the summary, standardization and quality control of chip data. Values of ≥2 and ≤-2 fold-change, as well as P\<0.05 were used for screening for differentially expressed genes. CLUSTER 3.0 software (Stanford University) with data adjustment functions was used to perform the log2 conversion and median calculation of chip data. Finally, the Java Treeview v1.8 (Stanford University School of Medicine) was used for cluster analysis. The samples were tested in triplicates.

RT-qPCR validation of differentially expressed lncRNAs and mRNAs
----------------------------------------------------------------

The criteria for selecting the candidate differentially expressed genes for validation were: i) Fold-change was ≥2; ii) the biological repeat of each group was ≥3; and iii) P≤0.05. For an upregulated gene, the number of samples with the detected flag of the experimental group was required to be \>60% of the total number of samples in the group. For a downregulated gene, the number of samples with the detected flag of the control group was required to be \>60% of the total number of samples in the group.

Therefore, according to bioinformatics, the relationship between the targeted regulation of the selected five lncRNAs and the mRNA microarray results (abnormal expression folds in the endometriosis group and the blank control group) were selected for four mRNAs \[ADAM metallopeptidase with thrombospondin type 1 motif 7 (Adamts7), tumor protein p53 (Tp53), distal-less homeobox 3 (Dlx3) and pyrimidinergic receptor P2Y6 (P2ry6)\] for qPCR validation.

The primers are shown in [Table I](#tI-ijmm-44-06-2145){ref-type="table"}. The FastQuant RT kit \[Tiangen Biotech (Beijing) Co., Ltd.\] was used for the reverse transcription of total RNA: 1 *µ*g total RNA and 20 *µ*l reaction system (10X Fast-RT Buffer 2 *µ*l, FQ-RT Primer Mix 2 *µ*l, RT Enzyme Mix 1 *µ*l, RNase-Free water 5 and 10 *µ*l buffer) were kept at 42°C for 15 min, 95°C for 3 min, cooled on ice and reverse transcribed. The same amount of RNA was used for all samples. The qPCR reaction system Power SYBR^®^-Green PCR Master Mix (Applied Biosystems; Thermo Fisher Scientific, Inc.; 10 *µ*l) containing Power SYBR^®^-Green PCR Master Mix (2X) 5 *µ*l, cDNA sample 0.5 *µ*l, forward primer (10 *µ*M, 0.25 *µ*l), reverse primer (10 *µ*M, 0.25 *µ*l) and nuclease-free water (4 *µ*l) were used in a MicroAmp Optical 96-Well Reaction Plate (Applied Biosystems; Thermo Fisher Scientific, Inc.). Denaturation was carried out at 95°C for 10 min in a QuantStudio™ 7 Flex RealTime PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.). Then, 40 cycles (95°C for 15 sec and 60°C for 1 min) and a final extension at 60°C for 10 min were performed, before climbing up to 95°C for melting curve analysis (temperature ramp of 2%). All RT-qPCR reactions were performed in triplicate. Electrophoresis (agarose gel, 2.0%) was used to detect the amplification specificity of the products. GAPDH was selected as the internal reference gene. Expression was measured using the 2^−ΔΔCq^ method ([@b17-ijmm-44-06-2145]).

Immunohistochemistry
--------------------

The SP method was used for immunohistochemistry ([@b18-ijmm-44-06-2145]). All specimens were fixed in neutral formalin (10%) for at least 24 h at room temperature, paraffin-embedded, sectioned (4 *µ*m) and dewaxed at 60°C overnight. Then, they were incubated in xylene for 45 min, hydrated in decreasing ethanol series and washed with distilled water for 5 min. After antigen retrieval, the slides were placed in PBS (pH 7.4), shaken and washed three times, 15 min each time. The sections were placed in hydrogen peroxide (3%) to block endogenous peroxidase and incubated at room temperature for 25 min. The slides were placed in PBS (pH 7.4), shaken and washed three times, 15 min each time. Bovine serum albumin (3%) (Wuhan Servicebio Technology, Co., Ltd.) was added and incubated at room temperature for 30 min. After adding antibodies against Adamts7 (1:200; cat. no. 250456; Abbiotec, Inc.), P2ry6 (1:50; cat. no. GTX16829; GeneTex, Inc.), Dlx3 (1:100; cat. no. 27-520; ProSci, Inc.) and Tp53 (1:200; cat. no. 70-527; ProSci, Inc.), the slides were incubated at 4°C in a wet box for the night. The DAKO K5007 rat/rabbit secondary antibody (cat. no. K5007; ready-to-use preparation; Dako; Agilent Technologies, Inc.) was added and incubated at room temperature for 50 min. DAB coloration (cat. no. G1211; Wuhan Servicebio Technology, Co., Ltd.) was performed and stained with hematoxylin for 3 min at room temperature, before observation under a light microscope.

Protein extraction and western blotting
---------------------------------------

The frozen uterine tissues were homogenized in 5X protein loading buffer (G2013; Wuhan Servicebio Technology, Co., Ltd.) with phosphorylation protease inhibitor (G2007; Wuhan Servicebio Technology, Co., Ltd.), cooled on ice for 30 min and centrifuged at 13,000 × g for 10 min at 4°C. The supernatant was kept. The bicinchoninic kit (Wuhan Servicebio Technology, Co., Ltd.) was used to determine protein concentration. The protein solution \[mixed 4:1 with 5X protein sample buffer (Wuhan Servicebio Technology, Co., Ltd.)\] was boiled for 15 min and stored at -20°C. Proteins (30 *µ*g) were separated using 10% SDS-PAGE. Proteins were transferred to polyvinylidene difluoride membranes, which were blocked with 5% skimmed milk for 1 h at room temperature. The primary antibodies against P2ry6 (1:1,000), Adamts7 (1:1,000), Dlx3 (1:1,000) and Tp53 (1:1,000; cat. no. orb319621; Biorbyt, Ltd.) were incubated at 4°C overnight. The membranes were washed in TBST (Tween-20, 0.05%) three times at room temperature. The secondary antibody HRP-labeled goat anti rabbit (1:3,000; cat. no. GB23303; Wuhan Servicebio Technology, Co., Ltd.) was incubated at room temperature for 30 min. The membranes were washed in TBST and enhanced chemiluminescence reagents A and B (cat. no. G2014; Wuhan Servicebio Technology, Co., Ltd.) was carried out. Adobe PhotoShop CS5 (Adobe Inc.) was used for image analysis. β-actin (1:3,000; cat. no. GB12001; Wuhan Servicebio Technology, Co., Ltd.) was selected as internal reference. Grey value analysis (alpha-EaseFC v4.0; Alpha Innotech Corporation) was carried out.

Functional prediction of lncRNAs and co-expression with mRNAs
-------------------------------------------------------------

As in a previous study ([@b19-ijmm-44-06-2145]), the Pearson correlation coefficient (PCC) between each abnormally expressed lncRNA and its co-expressed mRNA was calculated. PCC \>0.8 or \<0.8 and P\<0.01 represented significantly related lncRNA/mRNA. The hypergeometric cumulative distribution function was used to conduct functional enrichment analysis for co-expressed mRNA. The function of lncRNA was predicted through gene ontology (GO) (<http://geneontology.org/>) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis (<http://www.genome.jp/kegg/>). On this basis, protein regulatory genes could be predicted using cis and trans ([@b20-ijmm-44-06-2145],[@b21-ijmm-44-06-2145]). On the basis of the screening results of lncRNA and mRNA co-expression (correlation \>0.99 or \<-0.99 and P\<0.05), cis-prediction looked for lncRNA-mRNA pair whose genomic location was within 10 kb and trans-prediction used Blat (<http://hgdownload.cse.ucsc.edu/admin/exe/>) to compare lncRNA and mRNA (3′UTR) sequences, and selected lncRNA-mRNA pair that had similar sequence and beyond 100 kb distance.

Statistics analysis
-------------------

The tiff image data after hybrid scanning of the Gem^®^lncRNA+mRNA expression spectrum chip was preprocessed by the Feature Extraction software v10.7 (Agilent Technologies, Inc.). The GeneSpring GX software v13.0 (Agilent Technologies, Inc.) was used to calculate the differences of gene expression and statistical significance (P-value). Continuous data (such as the RT-qPCR data) were expressed as the mean ± standard deviation and analyzed using analysis of variance with post hoc Tukey\'s test. The Fisher\'s exact test was used to analyze GO and KEGG data. The PCC was used to calculate the co-expression relationship between lncRNA and mRNA. SPSS 19.0 (IBM, Corp.) was used to conduct statistical analysis. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

Endometriosis modeling was successful
-------------------------------------

On the 28th day after surgery, growth of ectopic endometrium of the transplanted tissues was 5×5 mm, tissue edema (a sign of inflammation) and vesicle formation ([Fig. 1A](#f1-ijmm-44-06-2145){ref-type="fig"}) were observed. All rats in the endometriosis group were scored 3 with well-preserved epithelium H&E staining showed that endometrial glands developed ([Fig. 1B](#f1-ijmm-44-06-2145){ref-type="fig"}). In the adipose tissue control group, there was no change in the transplant ([Fig. 1C](#f1-ijmm-44-06-2145){ref-type="fig"}) and H&E staining showed no endometrial glands ([Fig. 1D](#f1-ijmm-44-06-2145){ref-type="fig"}). The abdominal walls of rats in the blank control group were normal. According to observation and H&E staining, the success rate of the endometrial transplantation modeling was 100%.

Endometriosis is associated with differentially expressed lncRNAs
-----------------------------------------------------------------

Compared with the blank control group, the endometriosis model group showed 166 differentially expressed lncRNAs: 115 upregulated and 51 downregulated (fold-change \>2) ([Fig. 2A](#f2-ijmm-44-06-2145){ref-type="fig"} and [Tables II](#tII-ijmm-44-06-2145){ref-type="table"} and [III](#tIII-ijmm-44-06-2145){ref-type="table"}).

In order to confirm the results of the gene chip analysis, three lncRNAs with upregulated expression (gi\|672027621\|ref\|XR_592747.1\|, NONRATT006252 and gi\|672045999\|ref\|XR_591544.1\|) and two lncRNAs with downregulated expression were selected for RT-qPCR validation. The expression trend and amplitude were consistent with the results of the gene chip analysis ([Fig. 2B](#f2-ijmm-44-06-2145){ref-type="fig"}).

gi\|672066614\|ref\|XR_594547.1 (LOC103693263) was the most upregulated lncRNA \[fold-change (FC)=5.35; P\<0.01\] ([Tables II](#tII-ijmm-44-06-2145){ref-type="table"} and [III](#tIII-ijmm-44-06-2145){ref-type="table"}, and [Fig. 3](#f3-ijmm-44-06-2145){ref-type="fig"}). NONRATT006252 (FC=3.42; P\<0.01) and gi\|672045999\|ref\|XR_591544.1\| (FC=2.88, P\<0.01) were also significantly upregulated ([Tables II](#tII-ijmm-44-06-2145){ref-type="table"} and [III](#tIII-ijmm-44-06-2145){ref-type="table"}, and [Fig. 3](#f3-ijmm-44-06-2145){ref-type="fig"}).

NONRATT003997 was the most significantly downregulated (absolute FC=10.95; P\<0.01) ([Tables II](#tII-ijmm-44-06-2145){ref-type="table"} and [III](#tIII-ijmm-44-06-2145){ref-type="table"}, and [Fig. 3](#f3-ijmm-44-06-2145){ref-type="fig"}). gi\|672033904\|ref\|XR_589853.1\| was also significantly downregulated (absolute FC=5.79; P\<0.01) ([Tables II](#tII-ijmm-44-06-2145){ref-type="table"} and [III](#tIII-ijmm-44-06-2145){ref-type="table"}, and [Fig. 3](#f3-ijmm-44-06-2145){ref-type="fig"}).

Endometriosis is associated with differentially expressed mRNAs
---------------------------------------------------------------

Overall, 182 mRNA transcripts were differentially expressed: 97 were upregulated and 85 were downregulated (fold-change \>2) ([Fig. 4A](#f4-ijmm-44-06-2145){ref-type="fig"}). According to bioinformatics, four mRNAs (Adamts7, Tp53, Dlx3 and P2ry6) were selected in the prediction of target regulation relationship with five lncRNAs and gene chip results. RT-qPCR validation showed that the expression of those mRNA was consistent with the gene chip analysis ([Fig. 4B](#f4-ijmm-44-06-2145){ref-type="fig"}).

Adamts7 (A_44_P964460; FC=3.75, P\<0.01) and P2ry6 (A_64_P042495; FC=7.37; P\<0.05) were among the first 20 upregulated mRNAs ([Tables IV](#tIV-ijmm-44-06-2145){ref-type="table"} and [V](#tV-ijmm-44-06-2145){ref-type="table"} and [Fig. 5](#f5-ijmm-44-06-2145){ref-type="fig"}). Dlx3 was the second downregulated mRNA \[FC absolute (ABS)=7.79; P\<0.05\] [Tables IV](#tIV-ijmm-44-06-2145){ref-type="table"} and [V](#tV-ijmm-44-06-2145){ref-type="table"}, and [Fig. 5](#f5-ijmm-44-06-2145){ref-type="fig"}). Tp53 was among the first 20 downregulated mRNAs \[FC (ABS)=5.01, P\<0.01\] ([Tables IV](#tIV-ijmm-44-06-2145){ref-type="table"} and [V](#tV-ijmm-44-06-2145){ref-type="table"} and [Fig. 5](#f5-ijmm-44-06-2145){ref-type="fig"}).

Adamts7 and P2ry6 proteins are differentially expressed in endometriosis, but not Dlx3 and Tp53
-----------------------------------------------------------------------------------------------

Validation was performed using samples from 13 rats in the endometriosis group, eight in the adipose tissue control group and 14 in the blank control group. [Fig. 6A](#f6-ijmm-44-06-2145){ref-type="fig"} shows that Adamts7 was expressed in the uterine tissues of all three groups during the implantation stage, mainly in the endometrial stroma, glands and uterine cavity epithelium. The expression in the endometriosis group was upregulated significantly in comparison with the two control groups (adipose tissue and blank controls) in the three types of tissues (P\<0.05). The Adamts7 expression was significantly increased in the adipose tissue control group compared with in the blank control group in uterine stroma and glandular epithelium (P\<0.05; [Fig. 6B](#f6-ijmm-44-06-2145){ref-type="fig"}).

P2ry6 was expressed in the uterine tissues of all three groups of rats during the implantation stage, mainly in the endometrial stroma, glands and uterine cavity epithelium. The expression of P2ry6 was significantly increased in the endometriosis group compared with in the two control groups in the three tissue types (P\<0.05). The expression of P2ry6 was also significantly increased in the adipose tissue control group compared with in the blank control group in uterine epithelium and stroma (P\<0.05; [Fig. 6C](#f6-ijmm-44-06-2145){ref-type="fig"}).

Dlx3 was expressed in the uterine tissues of all three groups of rats, mainly in the endometrial stroma and uterine cavity epithelium. The expression in the glands was relatively weak. In the endometrial stroma and uterine epithelium, there was no significant difference in Dlx3 expression between the endometriosis and adipose tissue control groups (P=0.291 and P=0.98), and the expression in the endometriosis and adipose tissue control groups was significantly downregulated in comparison with the blank control group (P\<0.05). There were no significant differences in the expression of Dlx3 in the uterine glandular epithelium among the three groups (P=0.80; [Fig. 6D](#f6-ijmm-44-06-2145){ref-type="fig"}).

Tp53 was expressed in the uterine tissues of all three groups of rats, mainly in the endometrial stroma and uterine cavity epithelium. In all three tissue types, there was no significant difference in Tp53 expression between the endometriosis and adipose tissue control groups (P=0.089) and the expression the endometriosis and adipose tissue control groups was significantly downregulated in comparison with the blank control group (P\<0.05; [Fig. 6E](#f6-ijmm-44-06-2145){ref-type="fig"}).

Taken together, those results suggest that endometriosis is associated with increased protein expression of Adamts7 and P2ry6, while Dlx3 and Tp53 are not changed by endometriosis. Changes in Dlx3 and Tp53 protein expression could be due to the surgery.

Western blot analysis
---------------------

Adamts7 was significantly upregulated in the endometriosis group in comparison with the adipose tissue control group (P=0.002) and blank control group (P=0.003), and its expression in the adipose tissue control group was significantly upregulated compared with the blank control group (P=0.004; [Fig. 7A and B](#f7-ijmm-44-06-2145){ref-type="fig"}). The expression of P2ry6 in the endometriosis group was significantly upregulated compared with the adipose tissue control group (P=0.001) and blank control group (P=0.001), and its expression in the adipose tissue control group was significantly increased compared with in the blank control group (P=0.004; [Fig. 7A and C](#f7-ijmm-44-06-2145){ref-type="fig"}). The expression of TP53 in the adipose tissue control group was significantly down-regulated. compared with the blank control group (P=0.004; [Fig. 7A and E](#f7-ijmm-44-06-2145){ref-type="fig"}). The expression of Dlx3 in the endometriosis group was significantly downregulated compared with the adipose tissue control group (P= 0.002) and blank control group (P= 0.002); its expression in the adipose tissue control group was significantly downregulated compared with the blank control group (P= 0.002; [Fig. 7A and D](#f7-ijmm-44-06-2145){ref-type="fig"}). Taken together, those results show that the Adamts7 and P2ry6 proteins are upregulated by endometriosis, while Dlx3 and Tp53 are downregulated ([Fig. 7](#f7-ijmm-44-06-2145){ref-type="fig"}).

GO and KEGG analysis
--------------------

In the GO pathway analysis, the mRNAs that were abnormally expressed were mainly involved in cell differentiation, response to oxygen-containing compounds, ureteric bud morphogenesis, ureter maturation, embryonic organ morphogenesis, endocrine hormone secretion, female pregnancy, the immune response, response to steroid hormones, the ER-nucleus signaling pathway, parturition, response to oxidative stress, reproductive processes, response to estrogen, regulation of reproductive processes, *in utero* embryonic development and placenta development ([Table VI](#tVI-ijmm-44-06-2145){ref-type="table"}).

In the KEGG analysis ([Fig. 8](#f8-ijmm-44-06-2145){ref-type="fig"}), differentially expressed mRNAs were mainly involved in estrogen signaling pathway, GnRH signaling pathway, inflammatory mediator regulation of TRP channels, endometrial cancer, ovarian steroidogenesis, steroid hormone biosynthesis, apoptosis signaling pathway, insulin/IGF pathway-mitogen activated protein kinase/MAP kinase cascade, inflammation mediated by chemokine and cytokine signaling pathway.

In unsupervised hierarchical clustering analysis, the differentially expressed lncRNA ([Fig. 2A](#f2-ijmm-44-06-2145){ref-type="fig"}) and mRNA ([Fig. 4A](#f4-ijmm-44-06-2145){ref-type="fig"}) were used to generate heat maps, and they segregated into the endometriosis group and the normal control group clusters.

lncRNA and mRNA co-expression profiles and lncRNA function prediction
---------------------------------------------------------------------

Numerous lncRNA bind thousands of mRNA to achieve their biological functions. One lncRNA can bind to multiple mRNAs and one mRNA might be the target gene for multiple lncRNAs. For example, as shown in this study, Dlx3 was targeted by 32 lncRNA, TP53 was targeted by 35 lncRNA, P2ry6 was targeted by 33 lncRNA, Adamts7 was targeted by 40 lncRNA, NONRATT003997 targeted 21 mRNA, gi\|672027621\|ref\|XR_592747.1\| targeted 23 mRNA, gi\|672045999\|ref\|XR_591544.1\| targeted 29 mRNA, NONRATT006252 targeted 24 mRNA, and gi\|672033904\|ref\|XR_589853.1\| targeted 32 mRNA ([Tables VI](#tVI-ijmm-44-06-2145){ref-type="table"} and [V](#tV-ijmm-44-06-2145){ref-type="table"}). Taken together, these results indicate that the effect of endometriosis on uterine lncRNA and mRNA is complex ([Table VII](#tVII-ijmm-44-06-2145){ref-type="table"} and [Fig. 9](#f9-ijmm-44-06-2145){ref-type="fig"}).

Discussion
==========

The present study showed that there were 115 upregulated lncRNAs, 51 downregulated lncRNAs, 97 upregulated mRNAs and 85 downregulated mRNAs in the uterine tissues of rats with endometriosis, compared with the control group. The relative protein expression levels of Adamts7, P2ry6, Dlx3 and TP53 were different in the endometriosis group. Bioinformatics could predict the co-expression relationship of the selected five lncRNAs and four mRNAs. GO and KEGG analyses predicted that Adamts7, P2ry6, Dlx3, and TP53 were involved in endometriosis-related inflammation and reproductive pathways. Taken together, the results strongly suggest that the changes in the expression of lncRNAs, mRNAs and Adamts7, P2ry6, Dlx3 and TP53 proteins may possibly affect endometrial receptivity in rats with endometriosis during the implantation window.

Wang *et al* ([@b7-ijmm-44-06-2145]) found that the co-expression relationship of lncRNA(HOX)A11-AS1 (HOXA11 antisense RNA) and homeobox A (HOXA9, HOXA10, HOXA11 and HOXA13) played an important role in the pathogenesis of abdominal wall endometriosis. Powell *et al* ([@b22-ijmm-44-06-2145]) served the association among the allele 1p36.12 of LINC00339, blood CDC42 and endometriosis. Sun *et al* ([@b9-ijmm-44-06-2145]) found that 948 lncRNA transcripts and 4,088 mRNA transcripts were abnormally expressed in the ectopic endometrium of patients with endometriosis using gene chip technology. Ghazal *et al* ([@b5-ijmm-44-06-2145]) confirmed that H19 acted as a molecular sponge and attenuated the bioactivity of let-7 in the eutopic endometrium of patients with endometriosis; the expression of H19 in the endometrium of patients with endometriosis was significantly downregulated compared with those without endometriosis. Sigurgeirsson *et al* ([@b23-ijmm-44-06-2145]) found that the expression of 3,297 mRNAs, 516 lncRNAs and 102 small non-coding RNAs in the endometrium were significantly different between the proliferative phase and secretory phase of women\'s normal menstrual cycle (7-9 days after ovulation), and they speculated that the changes in the expression level of lncRNAs and mRNAs were probably the reasons for impaired endometrial receptivity. Shin *et al* ([@b24-ijmm-44-06-2145]) found that in the four-cell stage of embryo development in female rats, the X chromosome was selectively silenced and inactivated; during this process, lncRNAXist was activated by the downregulation of ubiquitin ligase Rnf12/RLIM3-5 in the embryonic cells. It has been shown that lncRNAs play a key role in human embryo implantation ([@b25-ijmm-44-06-2145]). In the present study, a rat endometriosis model was established by mating to obtain uterine tissues during the implantation window. This study is the first study to the best of our knowledge on the expression profile of lncRNA and mRNA in endometriosis during the implantation window.

Adamts7 belongs to a group of proteins that have platelet-associated activity ([@b26-ijmm-44-06-2145]). The overexpression of ADAMTS-7 promotes the decomposition of cartilage oligomeric matrix protein and accelerates the development of osteoarthritis induced by surgery and collagen-induced arthritis ([@b27-ijmm-44-06-2145]). In the present study, Adamts7 was mainly expressed in the endometrial stroma, glands and uterine cavity epithelium, the expression in the uterine tissues of rats with endometriosis was upregulated, and the expression in the adipose tissue control group was also upregulated in comparison with that of the blank control group. Therefore, it could be hypothesized that implantation failure in endometriosis during the implantation stage could be related to inflammation and the function of secretory glands.

Giannattasio *et al* ([@b28-ijmm-44-06-2145]) showed that as a G-protein combined receptor and a uridine diphosphate receptor, P2ry6 has a high affinity for G-protein combined receptor and uridine-2-phosphate receptor, which is an important endogenous inhibitor of the function of T cells in allergic pulmonary inflammation. Hamby *et al* ([@b29-ijmm-44-06-2145]) showed that transforming growth factor-β1, lipopolysaccharide, interferon-γ and other inflammatory factors can cause immune injury in astrocytes through the expression of P2ry6, leading to nervous system dysfunction. In the present study, the expression of P2ry6 in the uterine tissues of rats with endometriosis was upregulated during the implantation stage and the expression in the operation control group was upregulated in comparison with that of the blank control group. Therefore, this study considered that the gene regulation of P2ry6 in rats with endometriosis during the implantation window might be related to inflammation and hormone levels, which needs to be confirmed.

Dlx3 has been widely studied in the course of pregnancy and plays an important role in the formation of the placenta ([@b30-ijmm-44-06-2145]-[@b32-ijmm-44-06-2145]). DLX3 is expressed in the placenta tissues during human early pregnancy and plays an important regulatory role in the trophoblastic layer, syncytial layer and the formation of primary villi ([@b33-ijmm-44-06-2145]). Berghorn *et al* ([@b34-ijmm-44-06-2145]) showed that DLX3 in the placental tissues of 8.5-day mouse embryonic development was not detected, but DLX3 could be detected at 9.5 days and continued to 15.5 days. DLX3 produces 3β-hydroxysteroid dehydrogenase (VI) during the process of the secretion of progesterone by placental trophoblast cells and the expression of DLX3 is not detected in the embryonic stem cells (Rcho-1) of rats ([@b34-ijmm-44-06-2145]). In the present study, the expression of DLX3 in the endometrial stroma in rats with endometriosis during the implantation window was not significantly different from that of the operation control group and they were both decreased compared with in the blank control group. It was hypothesized that the effect of DLX3 on rats with endometriosis during the implantation window was mainly reflected in the endometrial stroma, which might not be related to gland activity and hormone levels, but more closely related to inflammation. Nevertheless, changes in the expression of DLX3 could be due to the surgery ([@b35-ijmm-44-06-2145]). Additional studies are necessary to examine this.

Tp53 acts as a bridge in the exchange process of pregnant mother and fetus in the early stages. The inactivation of Tp53 is affected by the preimplantation factor and may cause the apoptosis of placental cells, indicating that the interaction of Tp53 and implantation factors in human placental cytotrophoblasts promotes the survival and growth of embryonic cells ([@b36-ijmm-44-06-2145]). The expression profile of TP53 fluctuates during pregnancy ([@b37-ijmm-44-06-2145]). In human placental cells, adiponectin induces caspase activity by increasing the expression of TP53 and BAX, leading to a decrease in the expression of adiponectin receptors, and affecting the nutrient transport function of the placenta ([@b38-ijmm-44-06-2145]). Tp53 was also a downregulated gene in the uterine tissues of rats with endometriosis during the implantation window, but there was no significant difference between the endometriosis group and operation control group, both of them showing downregulated levels in comparison with those of the blank control group. Tp53 probably plays an important role in the formation of endometrial receptivity in rats with endometriosis during the implantation window, which might be related to the endometriosis-associated inflammatory characteristics and gland secretion. As for DLX3, changes in Tp53 could also be due to surgery ([@b39-ijmm-44-06-2145]). This will have to be examined in the future.

The present study is not without limitations. Although the present study could efficiently avoid the effects of the menstrual cycle in different individuals, it was still impossible to avoid the disadvantages of using animal experiments. There were also some differences among animals and the endometrium could not be separated because the uterine tissues of rats are too small. Therefore, the gene expression profile in the uterine tissues was decreased compared with the endometrium. Moreover, although human lncRNA sequence are highly similar to rats\', there are still some differences ([Table VIII](#tVIII-ijmm-44-06-2145){ref-type="table"}). Therefore, the next step will be to compare the degree of conservation of human and rat lncRNA sequences. On the basis of the obtained gene data of lncRNA and mRNA expression profiles in the uterine tissues of rats with endometriosis during the implantation window, five lncRNAs were compared with the conservative sequence of the human lncRNA database, showing that the lncRNAs were highly consistent. The correlation analyses indicate a relationship among the lncRNAs and mRNAs, but not the exact causal nature of the relationships. Finally, no functional and mechanistic experiments were performed to confirm the GO and KEGG results. Additional studies are still necessary to confirm the roles of the differentially expressed lncRNAs and mRNAs identified in the present study.

The results showed that the changes in the expression of lncRNAs, mRNAs and proteins (Adamts7, P2ry6, Dlx3 and TP53) may possibly affect the endometrial receptivity in rats with endometriosis during the implantation window, probably resulting in implantation failure of the embryo. This study provides new insights to investigate the pathogenesis of the disease and new clues about the possible causes of implantation failure in patients with endometriosis. It could ultimately reveal treatment targets for endometriosis infertility, but RNA stability is still a major barrier to the successful development of RNA therapeutics.
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![Endometriosis modeling is successful. (A) Volume growth, tissue edema and vesicle formation were observed in the endometriosis group. The arrow shows uterine tissue transplantation. (B) H&E staining showed that endometrial glands were developed in the endometriosis group (n=13). The arrow shows an endometrial gland. (C) In the adipose tissue control group (n=8), there was no change in the transplant. The arrow shows adipose tissue transplantation. (D) H&E staining showed no endometrial glands in the adipose tissue control group. Scale bar 100 *µ*m. The arrow show adipocytes. HE, hematoxylin and eosin.](IJMM-44-06-2145-g00){#f1-ijmm-44-06-2145}

![Compared with the blank control group (n=4), the endometriosis model group (n=4) shows 166 differentially expressed lncRNAs: 115 upregulated and 51 downregulated (fold-change \>2). (A) Gene chip analysis. (B) Reverse transcription-quantitative PCR confirmation using five lncRNAs. The samples were tested in triplicates. lnc, long noncoding.](IJMM-44-06-2145-g01){#f2-ijmm-44-06-2145}

![Changes in the expression of the five differentially expressed lncRNAs among the three groups. (A) gi\|672027621\|ref\|XR_592747.1\|, (B) gi\|672033904\| ref\|XR_589853.1, (C) gi\|672045999\|ref\|XR_591544.1\|, (D) NONRATT003997 and (E) NONRATT006252. ^\*\*^P\<0.01 vs. the normal control. lnc, long noncoding.](IJMM-44-06-2145-g02){#f3-ijmm-44-06-2145}

![Compared with the blank control group (n=4), the endometriosis model group (n=4) shows that 182 mRNA transcripts were different: 97 were upregulated and 85 were downregulated (fold-change \>2). (A) Gene chip analysis. (B) Reverse transcription-qPCR confirmation using four mRNAs. The samples were tested in triplicates. q, quantitative.](IJMM-44-06-2145-g03){#f4-ijmm-44-06-2145}

![Changes in the expression of the four differentially expressed mRNAs among the three groups. mRNA expression of (A) Adamts7, (B) P2ry6 (C) Dlx3 and (D) Tp53. ^\*^P\<0.05 and ^\*\*^P\<0.01 vs. the normal control. Adamts7, ADAM metallopeptidase with thrombospondin type 1 motif 7; Tp53, tumor protein p53; Dlx3, distal-less homeobox 3; P2ry6, pyrimidinergic receptor P2Y6.](IJMM-44-06-2145-g04){#f5-ijmm-44-06-2145}

![Immunohistochemistry of uterine tissue in rats. (A) Expression of Adamts7, P2ry6, Dlx3 and Tp53 in the endometriosis group (n=13), adipose tissue control group (n=8) and blank control group (n=14). (magnification, x200). Quantification of the immunohistochemistry results for (B) Adamts7, (C) P2ry6, (D) Dlx3 and (E) Tp53. The samples were tested in triplicates. ^\*^P\<0.05 vs. blank controls. ^\#^P\<0.05 vs. adipose tissue controls. Adamts7, ADAM metallopep-tidase with thrombospondin type 1 motif 7; Tp53, tumor protein p53; Dlx3, distal-less homeobox 3; P2ry6, pyrimidinergic receptor P2Y6; GE, glandular epithelium; St, endometrial stroma; UE, uterine epithelium.](IJMM-44-06-2145-g05){#f6-ijmm-44-06-2145}

![Western blot analysis of uterine tissue in rats. (A) Expression of Adamts7, P2ry6, Dlx3 and Tp53 in the endometriosis group (n=13), adipose tissue control group (n=8) and blank control group (n=14). Quantification of the western blotting results for (B) Adamts7, (C) P2ry6, (D) Dlx3 and (E) Tp53. The samples were tested in triplicates. β-actin was used to normalize the data. ^\*\*^P\<0.01 vs. normal control, ^\#\#^P\<0.01 vs. adipose tissue controls. Adamts7, ADAM metallopeptidase with thrombospondin type 1 motif 7; Tp53, tumor protein p53; Dlx3, distal-less homeobox 3; P2ry6, pyrimidinergic receptor P2Y6.](IJMM-44-06-2145-g06){#f7-ijmm-44-06-2145}

![KEGG analysis of differentially expressed lncRNAs. lnc, long noncoding; KEGG, Kyoto Encyclopedia of Genes and Genomes.](IJMM-44-06-2145-g07){#f8-ijmm-44-06-2145}

![Relationships among the five differentially expressed lncRNAs and the four mRNAs. The lncRNAs and mRNA shown here are those that were validated by quantitative PCR. The samples were tested in triplicates. lnc, long noncoding; Adamts7, ADAM metallopeptidase with thrombospondin type 1 motif 7; Tp53, tumor protein p53; Dlx3, distal-less homeobox 3; P2ry6, pyrimidinergic receptor P2Y6.](IJMM-44-06-2145-g08){#f9-ijmm-44-06-2145}

###### 

Primers for reverse transcription-quantitative PCR.

  Gene                                Primers (5′-3′)            Length
  ----------------------------------- -------------------------- --------
  NONRATT003997                       F: CAGGGTCGGGAAACTTTGAGA   22 bp
  R: CATCCAGTGTCCAGTGAGGG                                        
  gi\|672027621\|ref\|XR_592747.1\|   F: CACGGAATGACAAGTGTGGG    104 bp
  R: GGTGACTAATTGCCCCCGTA                                        
  gi\|672045999\|ref\|XR_591544.1\|   F: CAGCTGGATCTGCTTTCGGA    127 bp
  R: AGGAGACCCCAGATAAGCCT                                        
  NONRATT006252                       F: ACATAGCATTGGGCCCTGTC    134 bp
  R: TCTAAAAGTCTCAGAGCATTCTCAA                                   
  gi\|672033904\|ref\|XR_589853.1\|   F: AAGGGTTGGGAAGACCATGAC   120 bp
  R: GAGACTCCCTGCTCACTTACG                                       
  Adamts7                             F: TCAATTTCTGTGAGACGCTGC   147 bp
  R: ATGGTGCGTGGGTTTATCGT                                        
  Tp53                                F: CCCCACCGCCTGTAAGATTC    110 bp
  R: GAGGGGTGGGGGATGGATA                                         
  Dlx3                                F: TCAATCTCAATGGGCTCGCA    90 bp
  R: GGTACGCTCCATACTGTCGG                                        
  P2ry6                               F: GGTAGCTTGAGGCTGAGAGG    126 bp
  R: TGACAGAAGTGTGTACGGCAT                                       
  GAPDH                               F: CCTCAAGATCATCAGCAAT     141 bp
  R: CCATCCACAGTCTTCTGGGT                                        

Adamts7, ADAM metallopeptidase with thrombospondin type 1 motif 7; Tp53, tumor protein p53; Dlx3, distal-less homeobox 3; P2ry6, pyrimi-dinergic receptor P2Y6.

###### 

Top 20 upregulated lncRNA.

  lncRNA (probe name)                 FC (abs)   P-value    lncRNA (name)
  ----------------------------------- ---------- ---------- ---------------
  gi\|672066614\|ref\|XR_594547.1\|   5.34641    0.00327    LOC103693263
  gi\|672076298\|ref\|XR_595802.1\|   4.895411   0.02629    LOC103693752
  gi\|672079914\|ref\|XR_360377.2\|   4.506577   0.032437   LOC102548312
  gi\|672036138\|ref\|XR_590129.1\|   3.46012    0.001325   LOC103691084
  NONRATT018493                       3.433898   0.008362   
  NONRATT006252                       3.42446    0.01579    
  NONRATT020400                       3.267124   0.019514   
  NONRATT021467                       3.102348   0.007103   
  NONRATT025682                       3.051757   0.00634    
  NONRATT030954                       3.017166   0.011163   
  NONRATT011228                       3.015996   0.002754   
  NONRATT027460                       2.978006   0.018386   
  gi\|672045999\|ref\|XR_591544.1\|   2.87815    0.01452    LOC103691820
  NONRATT012251                       2.869275   0.01117    
  NONRATT016194                       2.819013   0.038048   
  NONRATT010960                       2.785293   0.022526   
  gi\|672052626\|ref\|XR_592505.1\|   2.765093   0.006744   LOC103692352
  gi\|672020316\|ref\|XR_346989.2\|   2.726432   0.001031   LOC102548283
  gi\|672037438\|ref\|XR_590367.1\|   2.619791   0.00196    
  NONRATT028550                       2.596784   0.019415   

lnc, long noncoding; abs, absolute.

###### 

Top 20 downregulated lncRNA.

  lncRNA (probe name)                 FC (abs)   P-value    lncRNA (name)
  ----------------------------------- ---------- ---------- ---------------
  NONRATT003997                       10.9511    0.00237    
  NONRATT024485                       10.62082   0.018243   
  NONRATT009394                       9.938666   0.044736   
  gi\|672086757\|ref\|XR_597443.1\|   8.693425   0.014136   LOC103694443
  NONRATT016350                       8.277449   0.007646   
  NONRATT001658                       7.982786   0.002575   
  NONRATT005792                       6.014078   0.00994    
  gi\|672033904\|ref\|XR_589853.1\|   5.79144    0.01007    LOC102546604
  NONRATT014091                       5.124274   0.014968   
  gi\|672040874\|ref\|XR_590738.1\|   4.626765   0.018434   LOC103691378
  uc.340                              3.967024   0.00138    
  NONRATT011360                       3.901989   0.002246   
  gi\|672030085\|ref\|XR_598174.1\|   3.857016   0.017871   LOC102553701
  gi\|672060549\|ref\|XR_355981.2\|   3.720889   0.007524   LOC102547634
  NONRATT003965                       3.631949   0.001985   
  gi\|672027547\|ref\|XR_592687.1\|   3.62932    0.002161   LOC102547023
  gi\|672034604\|ref\|XR_589986.1\|   3.453335   0.00527    LOC103690992
  NONRATT003634                       3.397446   0.014216   
  NONRATT018412                       3.134341   0.015503   
  gi\|672027788\|ref\|XR_340220.2\|   3.128051   0.010927   LOC102551595

lnc, long noncoding; abs, absolute.

###### 

Top 20 upregulated mRNA.

  Probe name      mRNA           FC (abs)   P-value
  --------------- -------------- ---------- ----------
  A_64_P366031    Cbln1          7.464442   0.002725
  A_64_P042495    P2ry6          7.37147    0.02699
  A_64_P066251    Ms4a14         5.004323   0.026015
  A_64_P021845    Tac3           4.34276    0.024744
  A_44_P241448    LOC102550973   3.948064   0.022094
  A_64_P057276    LOC102549073   3.933694   0.023946
  A_42_P817214    Efcab3         3.786581   0.004338
  A_44_P964460    Adamts7        3.75427    0.01493
  A_44_P506980    Pou3f4         3.655452   0.008571
  A_64_P044628    Agtr1b         3.09492    0.017631
  A_64_P012957    Dntt           3.094423   0.014797
  A_64_P016978    Zfp488         3.061541   0.003415
  A_64_P087831    Galnt13        3.038959   0.005398
  A_44_P135990    Cd3g           2.947655   0.002446
  A_64_P071732    Lrrc4c         2.944548   0.01782
  A_44_P375658    Nxph1          2.943451   0.002413
  A_44_P1071620   Sit1           2.608929   0.006022
  A_64_P059820    Xkr6           2.532615   0.013807
  A_64_P003997    Igsf1          2.527809   0.023865
  A_64_P113401    Fam183b        2.519156   0.00364

Abs, absolute.

###### 

Top 20 downregulated mRNA.

  Probe name     mRNA           FC (abs)   P-value
  -------------- -------------- ---------- ----------
  A_64_P009530   LOC687483      8.781071   0.003707
  A_44_P575055   Dlx3           7.794150   0.014970
  A_64_P142988   Fosb           7.026777   0.029057
  A_44_P295042   Cxcl5          6.987926   0.012344
  A_64_P094855   Slc46a2        5.017081   0.002092
  A_64_P121136   Tp53           5.013210   0.008090
  A_43_P11576    Hspa1b         4.539404   0.024537
  A_64_P043411   Elf3           4.520617   0.006673
  A_42_P576446   Krt17          4.418501   0.019014
  A_64_P062413   Calml3         4.182893   0.004898
  A_64_P017515   Ppp1r35        3.717559   0.014440
  A_64_P014090   Grp            3.703025   0.028939
  A_44_P271658   LOC100912449   3.625274   0.008212
  A_64_P072638   Jsrp1          3.393673   0.006873
  A_64_P124621   LOC102555023   3.319351   0.006541
  A_64_P135713   Mbnl3          3.274797   0.010593
  A_64_P113635   RGD1563753     3.230319   0.005243
  A_64_P031497   Murc           3.213777   0.013858
  A_44_P107653   Lrrc26         2.927319   0.027704
  A_64_P002809   Tubb4a         2.853953   0.008596

###### 

GO analysis of mRNA.

  Term                                                        ID           Background number   P-value
  ----------------------------------------------------------- ------------ ------------------- -------------
  Reproduction                                                GO:0000003   715                 0.934613717
  Steroid metabolic process                                   GO:0008202   205                 0.907802417
  Embryo development ending in birth or egg hatching          GO:0009792   519                 0.907802417
  Sexual reproduction                                         GO:0019953   543                 0.828851221
  Placenta development                                        GO:0001890   127                 0.809271211
  Steroid biosynthetic process                                GO:0006694   115                 0.785775079
  Embryonic epithelial tube formation                         GO:0001838   105                 0.767818727
  *In utero* embryonic development                            GO:0001701   321                 0.720657678
  Regulation of hormone secretion                             GO:0046883   196                 0.706512715
  Blastocyst development                                      GO:0001824   66                  0.655993287
  Embryonic heart tube development                            GO:0035050   64                  0.648745020
  Maternal process involved in female pregnancy               GO:0060135   59                  0.632235095
  Embryo development                                          GO:0009790   780                 0.605305219
  Response to estrogen                                        GO:0043627   231                 0.572555551
  Multicellular organismal reproductive behavior              GO:0033057   25                  0.453156618
  Hormone transport                                           GO:0009914   253                 0.437730680
  Chronic inflammatory response                               GO:0002544   22                  0.432311123
  Regulation of inflammatory response to antigenic stimulus   GO:0002861   20                  0.411517366
  Parturition                                                 GO:0007567   17                  0.389834482
  Uterus development                                          GO:0060065   16                  0.383439641

GO, gene ontology.

###### 

Expression of lncRNA and mRNA.

  Source                              Target         Correlation   P-value    Source gene symbol   Target gene symbol
  ----------------------------------- -------------- ------------- ---------- -------------------- --------------------
  gi\|672033904\|ref\|XR_589853.1\|   A_64_P135713   0.992091      0.000001   gi\|672033904        Dlx3
  NONRATT003997                       A_64_P135713   0.928748      0.000857   \-                   Dlx3
  gi\|672027621\|ref\|XR_592747.1\|   A_64_P135713   −0.92396      0.001037   gi\|672027621        Dlx3
  gi\|672033904\|ref\|XR_589853.1\|   A_64_P113635   0.961171      0.000142   gi\|672033904        Tp53
  NONRATT003997                       A_64_P113635   0.96782       0.000081   \-                   Tp53
  gi\|672045999\|ref\|XR_591544.1\|   A_64_P113635   −0.91168      0.00161    gi\|672045999        Tp53
  NONRATT006252                       A_42_P814235   0.957719      0.000183   \-                   P2ry6
  gi\|672027621\|ref\|XR_592747.1\|   A_42_P814235   0.919696      0.001218   gi\|672027621        P2ry6
  gi\|672045999\|ref\|XR_591544.1\|   A_42_P814235   0.919036      0.001248   gi\|672045999        P2ry6
  gi\|672033904\|ref\|XR_589853.1\|   A_44_P178519   −0.95751      0.000186   gi\|672033904        Adamts7
  NONRATT006252                       A_44_P178519   0.912129      0.001586   \-                   Adamts7
  NONRATT003997                       A_44_P178519   −0.9136       0.00151    \-                   Adamts7
  gi\|672027621\|ref\|XR_592747.1\|   A_44_P178519   0.921091      0.001157   gi\|672027621        Adamts7
  gi\|672045999\|ref\|XR_591544.1\|   A_44_P178519   0.944424      0.000411   gi\|672045999        Adamts7

lnc, long noncoding; Adamts7, ADAM metallopeptidase with thrombospondin type 1 motif 7; Tp53, tumor protein p53; Dlx3, distal-less homeobox 3; P2ry6, pyrimidinergic receptor P2Y6.

###### 

Comparison between rat and human lncRNA sequences.

  Rat lncRNA                          Human lncRNA                 \% identical   lncRNA ID
  ----------------------------------- ---------------------------- -------------- -------------------
  gi\|672027621\|ref\|XR_592747.1\|   p17451                       90.31          TCONS_00001579
  NONRATT022454                       p44032_v4                    83.45          uc001cvx.3
  gi\|672045999\|ref\|XR_591544.1\|   p10107                       83.29          ENST00000563759.1
  NONRATT014258                       RNA40309\|RefSeq_2352_1430   90.06          
  NONRATT011779                       RNA38792\|RefSeq_733_3290    81.9           
  NONRATT029450                       RNA42607\|UCSC_176_6901      100            
  NONRATT028550                       p28817                       86.47          LIT3372
  NONRATT003997                       p37546_v4                    84.17          ENST00000514073.1
  NONRATT027560                       p28817                       81.42          LIT3372
  NONRATT000719                       RNA45098\|UCSC_3204_2521     88             
  NONRATT017840                       RNA43455\|UCSC_1198_3829     81.71          

lnc, long noncoding.
